Latest 30 News in the Life Sciences Industry
PR Newswire Association LLC.
BioLineRx and Hemispherian Announce Two GLIX1 Presentations at the 31st Society for Neuro-Oncology (SNO) Annual Meeting & Education Day
08 Oct 2026
PR Newswire Association LLC.
Ribo Submits European Clinical Trial Application for Phase Ⅰ Study of INHBE-Targeting siRNA RBD3133
08 Oct 2026
PR Newswire Association LLC.
SciBase resolves on a set-off issue of shares to the guarantor in connection with the completed rights issue
07 Oct 2026
PR Newswire Association LLC.
SciBase: Recalculation of warrants of series TO 2 following rights issue
07 Oct 2026
PR Newswire Association LLC.
Roche Diagnostics delivers laboratory equipment to support Ebola testing in DRC
07 Oct 2026
PR Newswire Association LLC.
Natural Cycles deepens investment in Canada following 3x user growth
07 Oct 2026
PR Newswire Association LLC.
Lundbeck presents Phase Ib data for Lu AF28996 in advanced Parkinson's disease, as Phase II trial begins
06 Oct 2026
PR Newswire Association LLC.
Beactica Therapeutics selects BEA-28 as a preclinical candidate, a first-in-class TEAD degrader for biomarker-selected cancers
06 Oct 2026
PR Newswire Association LLC.
Stryker Launches Mako 4 SmartRobotics™ in India, Advancing the Next Generation of Robotic-Assisted Joint Replacement
05 Oct 2026
PR Newswire Association LLC.
Driving Community Health: Bristol Myers Squibb, Emirates Thalassemia Society and Dubai Science Park Host the 6th 'Help Save a Life' Blood Donation Drive
05 Oct 2026
PR Newswire Association LLC.
AbbVie and Genmab Announce Epcoritamab in Combination with R-CHOP Demonstrates Significant Improvement in Progression-Free Survival versus R-CHOP in Patients with Newly Diagnosed Diffuse Large B-Cell Lymphoma
05 Oct 2026
PR Newswire Association LLC.
New analyses on terbinafine susceptibility and MOB-015 published in Journal of Fungi
05 Oct 2026
PR Newswire Association LLC.
Lundbeck to showcase progress across its movement disorders pipeline with data in multiple system atrophy and Parkinson's disease at MDS® 2026
02 Oct 2026
PR Newswire Association LLC.
Skanska signs additional contract for new hospital in Fort Myers, Florida, USA, for USD 60M, about SEK 560M
02 Oct 2026
PR Newswire Association LLC.
Samfara completes acquisition of Chr. Olesen Synthesis, Danish manufacturer of controlled-substance APIs
02 Oct 2026
PR Newswire Association LLC.
ADAMA Launches Botanical Fungicide Actavan® in Australia and New Zealand
01 Oct 2026
PR Newswire Association LLC.
Lundbeck announces headline results from Phase IV THRIVE trial evaluating VYEPTI® (eptinezumab) following inadequate response to prior CGRP-targeting preventive therapy
01 Oct 2026
PR Newswire Association LLC.
People switching from weight-loss injections to Novo's Wegovy® pill lost 4.1% body weight on average after three months, according to real-world data presented at EASD2026
30 Sep 2026
PR Newswire Association LLC.
Australia's biosolutions sector could nearly triple to AUD$ 13.1 billion by 2035
30 Sep 2026
PR Newswire Association LLC.
Roche launches newborn screening test for three severe genetic conditions
30 Sep 2026
PR Newswire Association LLC.
AsiaMedic becomes first in ASEAN to expand MRI capabilities with next-generation deep learning technology
30 Sep 2026
PR Newswire Association LLC.
EQT Foundation commits more than €1 million to help unlock new ways of delivering medicines to the brain
30 Sep 2026
PR Newswire Association LLC.
Novo's Ozempic® (semaglutide) 2 mg associated with lower risk of major adverse cardiovascular events (death, heart attack, and stroke) in adults with type 2 diabetes compared to switching to Mounjaro® (tirzepatide), in real-world analysis at EASD
29 Sep 2026
Upcoming Events All Events
- October 2026
- Milan: CPHI Milan 2026
- Basel: 26th Annual Biotech in Europe Forum
- Yokohama: BioJapan